Teleradiology boosts Lumisys revenues
X-ray film digitizer manufacturer Lumisys said growth in the teleradiologymarket has increased the company's sales for its second quarter(end-June). Net income dropped, however, due to the expirationof tax benefits the Sunnyvale, CA, company had been
X-ray film digitizer manufacturer Lumisys said growth in the teleradiologymarket has increased the company's sales for its second quarter(end-June). Net income dropped, however, due to the expirationof tax benefits the Sunnyvale, CA, company had been using.
For the quarter, Lumisys had sales of $5.9 million, up 26%over sales of $4.7 million in the same period the year before.Net income was $896,000, compared with $1.4 million in the secondquarter of 1995.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
